Ausgabe Sonderheft 2/2015
Chronic Myeloid Leukemia
Inhalt (16 Artikel)
Open Access
Review Article
The choice of first-line Chronic Myelogenous Leukemia treatment
Carmen Fava, Giovanna Rege-Cambrin, Giuseppe Saglio
Review Article
Causes of resistance and treatment choices of second- and third-line treatment in chronic myelogenous leukemia patients
Andreas Hochhaus, Thomas Ernst, Ekkehard Eigendorff, Paul La Rosée
Review Article
A review of the European LeukemiaNet recommendations for the management of CML
Michele Baccarani, Fausto Castagnetti, Gabriele Gugliotta, Gianantonio Rosti
Review Article
Management of adverse events associated with tyrosine kinase inhibitors in chronic myeloid leukemia
Delphine Rea
Review Article
Managing pregnancy in chronic myeloid leukaemia
Renuka Palani, Dragana Milojkovic, Jane F. Apperley
Review Article
The role of hematopoietic stem cell transplantation in chronic myeloid leukemia
Alois Gratwohl, Helen Baldomero, Jakob Passweg
Review Article
Prognostic scores for patients with chronic myeloid leukemia under particular consideration of competing causes of death
Markus Pfirrmann, Michael Lauseker, Verena S. Hoffmann, Joerg Hasford
Review Article
Molecular monitoring of chronic myeloid leukemia: principles and interlaboratory standardization
Nicholas C. P. Cross, Andreas Hochhaus, Martin C. Müller
Review Article
Response-related predictors of survival in CML
Benjamin Hanfstein, Martin C. Müller, Andreas Hochhaus
Review Article
Epidemiology of chronic myeloid leukaemia: an update
Martin Höglund, Fredrik Sandin, Bengt Simonsson
Review Article
Changing the cost of care for chronic myeloid leukemia: the availability of generic imatinib in the USA and the EU
Rena M. Conti, William V. Padula, Richard A. Larson